---
figid: PMC5455318__JCO.2016.67.4044f2
figlink: /pmc/articles/PMC5455318/figure/F2/
number: Fig 2
caption: Effects of hyperinsulinemia on the tumor cell microenvironment and intracellular
  signaling that contribute to tumor growth and progression. The schematic depicts
  the potential direct and indirect effects of insulin on tumor growth. Insulin and
  insulin-like growth factors 1 and 2 (IGF-1 and IGF-2) bind to the two insulin receptor
  (IR) isoforms (IR-A, IR-B), IGF-1 receptor (IGF-1R), and IR/IGF-1R hybrid receptors
  (IR-A/IGF-1R, IR-B/IGF-1R) with different affinities. Solid arrows indicate strong
  affinity for the receptor, and dashed arrows represent weak affinity for the receptor.
  IGF-binding proteins (IGFBP) 1 and 2 are decreased by insulin and may result in
  increased bioavailable IGF-1 and IGF-2. Binding of insulin to IR primarily activates
  the phosphoinositide 3-kinase (PI3K)–Akt–mammalian target of rapamycin (mTOR) signaling
  pathway. Binding of IGF-1 and IGF-2 to IGF-1R stimulates the PI3K-Akt-mTOR and Ras-Raf-MAPK
  pathways. Increased local production of estrogen may occur as a result of increased
  expression of aromatase, activating estrogen receptor α in tumor cells. Inflammation
  in the tissue microenvironment may also be increased by hyperinsulinemia, which
  leads to local cytokine production and activation the Jak-Stat signaling pathway
  in the tumor. Erk, extracellular regulated kinase; IL, interleukin; IRS1/2, insulin
  receptor substrate; TNF, tumor necrosis factor.
pmcid: PMC5455318
papertitle: 'Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.'
reftext: Gadi Shlomai, et al. J Clin Oncol. 2016 Dec 10;34(35):4261-4269.
pmc_ranked_result_index: '73855'
pathway_score: 0.95142
filename: JCO.2016.67.4044f2.jpg
figtitle: Hyperinsulinemia on the tumor cell microenvironment and intracellular signaling
  that contribute to tumor growth and progression
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5455318__JCO.2016.67.4044f2.html
  '@type': Dataset
  description: Effects of hyperinsulinemia on the tumor cell microenvironment and
    intracellular signaling that contribute to tumor growth and progression. The schematic
    depicts the potential direct and indirect effects of insulin on tumor growth.
    Insulin and insulin-like growth factors 1 and 2 (IGF-1 and IGF-2) bind to the
    two insulin receptor (IR) isoforms (IR-A, IR-B), IGF-1 receptor (IGF-1R), and
    IR/IGF-1R hybrid receptors (IR-A/IGF-1R, IR-B/IGF-1R) with different affinities.
    Solid arrows indicate strong affinity for the receptor, and dashed arrows represent
    weak affinity for the receptor. IGF-binding proteins (IGFBP) 1 and 2 are decreased
    by insulin and may result in increased bioavailable IGF-1 and IGF-2. Binding of
    insulin to IR primarily activates the phosphoinositide 3-kinase (PI3K)–Akt–mammalian
    target of rapamycin (mTOR) signaling pathway. Binding of IGF-1 and IGF-2 to IGF-1R
    stimulates the PI3K-Akt-mTOR and Ras-Raf-MAPK pathways. Increased local production
    of estrogen may occur as a result of increased expression of aromatase, activating
    estrogen receptor α in tumor cells. Inflammation in the tissue microenvironment
    may also be increased by hyperinsulinemia, which leads to local cytokine production
    and activation the Jak-Stat signaling pathway in the tumor. Erk, extracellular
    regulated kinase; IL, interleukin; IRS1/2, insulin receptor substrate; TNF, tumor
    necrosis factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - IRS1
  - TYK2
  - IGF2
  - IGF1
  - PIK3CA
  - JAK1
  - PIK3CD
  - IRS2
  - PIK3R3
  - PIK3CB
  - ARAF
  - PIK3CG
  - MAPK1
  - BRAF
  - STAT6
  - STAT1
  - STAT2
  - STAT5B
  - TNF
  - PIK3R5
  - PIK3R4
  - STAT5A
  - MAPK3
  - JAK2
  - NRAS
  - AKT1
  - RAF1
  - PIK3R6
  - AKT2
  - JAK3
  - STAT3
  - KRAS
  - HRAS
  - STAT4
  - AKT3
  - Cancer
genes:
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IRS1/2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: ↑IGF-2
  symbol: IGF2
  source: hgnc_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: IGF-2
  symbol: IGF-II
  source: hgnc_alias_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: ↑IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: IRS1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: ↑TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
